Who funds schizophrenia research?

We count 51 funded schizophrenia projects, active between 2023 and 2033, from 4 funders. The most came from Wellcome (14 projects), EU · MSCA (9 projects) and NIH · NIMH (8 projects). The median award is $1.6M, across the 47 of 51 projects that list an amount.

Funded projects

51

Funders

4

Median award

$1.6M

Open calls now

2

Top funders of schizophrenia research

Projects whose title or summary mentions schizophrenia. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open schizophrenia funding calls

2 open calls mention schizophrenia today.

• Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
  National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
  Real odds: About 1 in 8 funded (13% · NIH R01-equivalent grants, all NIH institutes, FY2025)
• Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
  National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
  Real odds: About 1 in 9 funded (11% · NIH R21 (exploratory/developmental), all NIH institutes, FY2025)

Real odds

• About 1 in 8 funded · 13% · NIH R01-equivalent grants, all NIH institutes, FY2025 · NIH Data Book, report 29
• About 1 in 9 funded · 11% · NIH R21 (exploratory/developmental), all NIH institutes, FY2025 · NIH Data Book, report 202

Published success rates for the programs behind the open calls above: the share of applications the funder funded, program-wide, not for this topic.

Funded schizophrenia projects

A sample, latest start first, at most three per program.

• Visual selection through learning and attention in visual and parietal cortex for decision-making and action
  Wellcome · £1,759,243 · ends 2033
• Investigating the roles of R-loops and mutations in the pathogenesis of neurodevelopmental disorders
  Wellcome · £1,834,521 · ends 2031
• Duke Conte Center for Basic Neuroscience on Kinase Signaling in Neurodevelopmental Disorders
  NIH · NIMH · $3,068,480 · ends 2031
• From premature to protracted decision-making: Neural mechanisms underlying transdiagnostic biases in deliberation
  Wellcome · £390,002 · ends 2031
• Advancing methods for pharmacological fMRI to improve discovery and development of treatments for mental health
  UKRI · MRC · £1,963,070 · ends 2031
• Determining if mitochondrial complex I underlies neural dysfunction in schizophrenia
  UKRI · MRC · £1,539,301 · ends 2030
• PROSPECT: Predicting psychosis outcomes from speech and brain connectivity
  UKRI · UKRI FLF · £1,835,657 · ends 2029
• Early Life Air Pollution Exposures as a Risk Factor for Neurodevelopmental Disorders
  NIH · NIEHS · $3,238,988 · ends 2029
• Clinical Trial Data Processing, Analysis, and Coordination Center (CT-DPACC) for Accelerating Medicines Partnership Schizophrenia (AMP SCZ) Project
  NIH · NIMH · $5,958,622 · ends 2029
• EPSRC-FAPESP Predicting Critical Transitions in Complex Dynamical Networks: Reduction and Learning
  UKRI · EPSRC · £648,144 · ends 2029

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “schizophrenia”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.